fulvestrant has been researched along with Cardiovascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Esteva, FJ; Hortobagyi, GN | 1 |
| Arriero, MD; Casado, S; de Frutos, T; Díaz-Recasens, J; Farré, J; García, R; García-Durán, M; García-Gálvez, G; González-Fernández, F; Jiménez, A; López-Farré, A; Montón, M; Rico, L; Sánchez de Miguel, L | 1 |
1 review(s) available for fulvestrant and Cardiovascular Diseases
| Article | Year |
|---|---|
Comparative assessment of lipid effects of endocrine therapy for breast cancer: implications for cardiovascular disease prevention in postmenopausal women.
Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Estradiol; Female; Fulvestrant; Hormone Replacement Therapy; Humans; Lipids; Middle Aged; Nitriles; Osteoporosis, Postmenopausal; Risk Factors; Tamoxifen; Triazoles; Triglycerides | 2006 |
1 other study(ies) available for fulvestrant and Cardiovascular Diseases
| Article | Year |
|---|---|
Estrogen stimulates neuronal nitric oxide synthase protein expression in human neutrophils.
Topics: Adult; Aged; Cardiovascular Diseases; CD18 Antigens; Cell Adhesion; Enzyme Induction; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Hormone Replacement Therapy; Humans; Luteinizing Hormone; Male; Menstrual Cycle; Middle Aged; Neutrophils; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; omega-N-Methylarginine; Postmenopause; Premenopause; Receptors, Estrogen; Sex Characteristics; Tamoxifen | 1999 |